By the end of this video, you'll know exactly what Neuralink has accomplished so far, and what the company plans to do next. We'll go over how many people are living with the implant, what they can currently do with it, how Neuralink expanded trials across multiple countries, and what new features like speech decoding and vision restoration are on the horizon. Founded by Elon Musk in 2016, Nurling set out to build the world's first scalable brain computer interface.Technology that could restore movement, sp ...

Summary of Key Points from the Conference Call Industry Overview - **Industry**: Robotics in North America - **Focus**: Predictions for the robotics sector in 2026 Core Insights and Arguments 1. **Humanoid Robotics**: There is significant potential for humanoid robots, but current developments are more focused on marketing and funding rather than practical applications. The challenges include morphology, environment, and task-specific training [4][4][4] 2. **Autonomous Vehicles (AVs)**: The transition of robotaxis from concept to reality is anticipated in 2026, with companies like Tesla and Waymo leading the charge. Tesla has already begun pulling drivers in certain states, while Waymo is expanding its operational cities [4][4][4] 3. **Federal Regulations**: The expected rise in AVs will necessitate faster regulatory developments in the U.S. to keep pace with advancements in China [4][4][4] 4. **Drones and Low Altitude Economy**: The Low Altitude Economy (LAE) is highlighted as a critical area of competition between the U.S. and China, with advancements in AI and drone technology driving market growth [4][4][4] 5. **Automotive OEMs and Robotics**: Traditional automotive manufacturers are expected to fully embrace robotics, following the lead of companies like BYD and Xiaomi [4][4][4] 6. **China-U.S. Collaboration**: The potential for competitive collaboration between the U.S. and China is noted, particularly in advanced manufacturing and supply chains, with examples like Apple's robotics efforts [4][4][4] 7. **Emergence of a $1 Trillion Unicorn**: The research team is exploring private companies pushing the boundaries of embodied AI, with the potential for significant market impact [4][4][4] 8. **Mag 7 Companies**: Key players in the tech industry are expected to increasingly discuss robotics and AI in their communications, indicating a trend towards real-world data collection and partnerships [4][4][4] 9. **Tesla and xAI**: Tesla's convergence with xAI is noted, with the potential for significant advancements in robotics and AI capabilities [7][7][7] 10. **Brain-Computer Interfaces (BCI)**: Progress in BCI technology is expected to lead to superhuman capabilities, particularly in clinical trials and applications like video gaming [7][7][7] Additional Important Content - **Valuation Methodology for Tesla**: The price target for Tesla is set at $410, based on various components including core auto business, network services, mobility, and energy segments [8][8][8] - **Risks**: Several risks are identified, including competition from legacy OEMs and execution risks related to factory ramp-ups [11][11][11] - **Stock Ratings**: The report includes stock ratings for various companies in the automotive and shared mobility sectors, indicating a mix of overweight, equal-weight, and underweight ratings [67][67][67] This summary encapsulates the key points discussed in the conference call, focusing on the robotics industry and its future trajectory, particularly in relation to autonomous vehicles and humanoid robotics.

Hey everyone, I wanted to jump on here and share some breaking news. Neuralink has implanted in their first human trial participant in the United Kingdom. Earlier today on X, they announced this. They said, "We excited to announce our first participant in the UK. Paul, who is paralyzed due to motor neuron disease, received his Neurolink implant at UCLH earlier this month and was able to control a computer with his thoughts just after surgery. And the University of College London Hospitals is UCLH.Um, there' ...

RT DogeDesigner (@cb_doge)🚨BREAKING: Neuralink’s first patient in the UK, Paul, who is paralyzed by motor neuron disease, has received a brain implant.Just hours after surgery, he was able to control a computer with his thoughts and is now using it to play games and regain independence. https://t.co/3u5nh4RCYu ...

Core Viewpoint - ONWARD Medical N.V. is launching a capital increase through a private placement aimed at raising approximately EUR 50 million to support its operations and development initiatives in neurotechnology for spinal cord injuries and movement disabilities [1][2]. Summary by Sections Private Placement Overview - The private placement will involve the issuance of new ordinary shares with a nominal value of EUR 0.12 each, offered to qualified institutional investors [1][3]. - The final number of shares and the issue price will be determined through a bookbuilding process, which is expected to last one business day [4][5]. Use of Proceeds - The net proceeds from the private placement will be allocated as follows: - 40% for product development, clinical studies, and regulatory activities for the ARC-IM System - 30% to expand sales and operations for the ARC-EX System - 20% to support quality and administrative activities - 5% for working capital and general corporate purposes - 5% to cover financing costs, including existing debt obligations [2][6]. Trading and Regulatory Aspects - Trading of ONWARD Medical's shares will be temporarily suspended on Euronext Brussels, Amsterdam, and Paris during the bookbuilding period to facilitate broader investor participation [5][7]. - The new shares are expected to be listed and admitted to trading on October 28, 2025, with payment and delivery occurring on the same day [9]. Company Background - ONWARD Medical is a leading neurotechnology company focused on therapies to restore movement and independence in individuals with spinal cord injuries and other movement disabilities [11]. - The company has developed the ARC Therapy and has received multiple Breakthrough Device Designations from the FDA for its products [11].

Company Progress & Technology - Neuralink is developing brain-computer interfaces with the goal of restoring capabilities for paralyzed individuals, those who have lost the ability to speak, and the blind [2] - Neuralink uses custom-built 3D models called proxies, mimicking a person's anatomy, for lab testing before animal or human trials [1] - Meta is also developing neural interfaces, including a neural band wristband, for controlling devices with subtle muscle movements [2][3] - Neuralink has implanted devices in at least 12 patients, including two surgeries in Canada, marking its first procedures outside the United States [3][4] - Neuralink aims to restore limited sight to the completely blind next year [5] - Neuralink is exploring the hippocampus for potential treatments of psychiatric diseases and epilepsy by 2028 [5][6][7][8] Patient Impact & Barrow Neurological Institute - Nolan, the first Neuralink patient, publicly shares his positive experiences with the technology, advocating for its potential to change lives [3] - Barrow Neurological Institute is recognized as the site for the first robotically implanted brain-computer interface and has treated the most Neuralink patients globally, with seven implants [3] Future Directions - Neuralink is considering prioritizing an implant to eliminate back and neck pain [1][2]

Technology Advancement - Neuralink's technology could enable individuals with implants to surpass professional gamers in under a decade [1] - Neuralink aims to enhance reaction time and precision through brain-computer interfaces, eliminating the need for traditional input devices like keyboards [1]

This Startup Lets Paralyzed People Use Computers–Without A Chip In Their Head https://t.co/Fe6IPBADue https://t.co/PLxHxBGWWl ...

Technology & Healthcare Innovation - A startup enables paralyzed individuals to use computers without brain implants [1] Accessibility & Assistive Technology - The technology offers a non-invasive alternative for computer interaction [1]

Technological Advancements & Performance - Neuralink study has expanded to 9 participants, with further growth anticipated [2] - The Neuralink chip demonstrates improvements in speed, stability, and model responsiveness, reducing the need for frequent recalibration [4] - Calibration time is trending towards negligible, indicating progress towards a true plug-and-play brain-computer interface [4] - User consistently uses the implant for more than 10 hours a day [10] Future Applications & Development - Neuralink is exploring applications beyond cursor control, including smart home systems, robotic limbs, and communication tools [6] - Future research may focus on using the implant for input, such as regulating mood, managing pain, helping with memory, and restoring senses [7][8] - Improvements have been made to the charger for increased reliability and user-friendliness [9] - Data collection has become smoother, leading to better performance and outcomes [9] User Impact & Potential - The technology aims to restore dignity, independence, freedom, purpose, and hope for users [16] - Neuralink enables user to write speeches, email clients, study topics, and run a business [12]